What is the current stock price of ViroGates A/S (VIRO.CO)?

As of the latest market data, ViroGates A/S (VIRO.CO) is trading at $0.00. The stock has seen a loss of undefined% today.

Does ViroGates A/S (VIRO.CO) pay a dividend?

Based on current data, ViroGates A/S does not have a confirmed active dividend policy.

What is the market cap of ViroGates A/S?

The current market capitalization of ViroGates A/S (VIRO.CO) is approximately unavailable.

VIRO.CO

ViroGates A/S·Healthcare

0.00

0.000%(+0.00)

Close Price

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

ViroGates A/S develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a blood test that measures the soluble urokinase plasminogen activator receptor (suPAR) protein in the bloodstream used for emergency departments in hospitals to improve clinical decisions on hospitalization or discharge of acute medical patients and reduce healthcare cost. The company also provides suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the suPAR level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic Quick Triage kit, which is used in the point of care situation for early warning and patient triaging; and suPARnostic ELISA that provides fully quantitative results. Its suPAR prognostic tool used in various diseases, such as cardiovascular, kidney, cancer, diabetes, liver, infectious, respiratory, and rheumatic. The company was incorporated in 2000 and is headquartered in Birkerød, Denmark.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2018-06-26

Beta

0.73

Websitewww.virogates.com↗